MedPath

Flourish Vaginal Care System to Establish Neovaginal Microbiome

Not Applicable
Completed
Conditions
Neovaginal Microbiome
Registration Number
NCT05372770
Lead Sponsor
Vaginal Biome Science
Brief Summary

This study examines whether use of a commercially-available vaginal wellness system is able to establish a microbiome in transgender women.

Detailed Description

Very little is known about the neovaginal microbiome, but it has been described as being a polymicrobial state similar to bacterial vaginosis (BV) in cis women. The Flourish Vaginal Care System is a commercially-available over-the-counter vaginal wellness kit that helps relieve symptoms of BV. This study is intended to determine whether that kit could also help transgender women who have recently undergone gender-confirming surgery to establish a neovaginal microbiome that is dominated by lactobacilli, as observed in healthy cis women. This could increase health and subjective satisfaction of the neovagina. This study examines the (neo)vaginal microbiome in transgender women with and without using Flourish, as well as a group of healthy cisgender women.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  1. Transgender women over age 18 who are preparing to undergo gender-confirmation surgery.
  2. Healthy cisgender women ages 18-52
Exclusion Criteria
  1. Immunosuppressed
  2. Known allergies or sensitivities to aloe vera or to other components of Restore®, Balance, or BiopHresh®
  3. Known (neo)vaginal infection that is not yeast or BV at start of protocol
  4. Inability to tolerate Restore gel by day 13 after surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Vaginal microbiomeCollections at time 0, 6 weeks, and 6 months

Observation of changes in the composition of the vaginal fluid microbiome over six months using commercially available next-generation sequencing kit (16s rRNA). Biomes will be categorized to "community state type" (Ravel 2011), and genus- or species-level relative abundance will be compared.

Vaginal pHCollections at time 0, 6 weeks, and 6 months

Observation of changes in vaginal pH over six months by pH strip

Secondary Outcome Measures
NameTimeMethod
VSQCollections at time 0, 6 weeks, and 6 months

Responses to the Vulvovaginal Symptoms Questionnaire

Trial Locations

Locations (1)

Papillon Wellness Center

🇺🇸

New Hope, Pennsylvania, United States

Papillon Wellness Center
🇺🇸New Hope, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.